MediXall Group, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
MediXall Group, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2022.
  • MediXall Group, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $7.57M, a 30.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $7.57M +$1.78M +30.6% Dec 31, 2022 10-K 2023-08-09
Q4 2021 $5.8M +$1.61M +38.5% Dec 31, 2021 10-K 2023-08-09
Q4 2020 $4.19M +$1.54M +58.3% Dec 31, 2020 10-K 2022-04-19
Q4 2019 $2.64M +$889K +50.7% Dec 31, 2019 10-K 2021-06-17
Q4 2018 $1.75M +$776K +79.3% Dec 31, 2018 10-K 2020-05-14
Q4 2017 $978K -$958K -49.5% Dec 31, 2017 10-K 2019-05-16
Q4 2016 $1.94M +$223K +13% Dec 31, 2016 10-K/A 2018-03-05
Q4 2015 $1.71M Dec 31, 2015 10-K 2017-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.